Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus (Q73407589)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

systemic lupus erythematosus

3 November 2019

main subject

0 references

author name string

T J Lehman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

K Onel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

243-247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

A practical guide to systemic lupus erythematosus.

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Systemic lupus erythematosus within the first two decades of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Systemic lupus erythematosus in children: the complex problems of diagnosis and treatment encountered in 101 such patients at the Mayo Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Intermittent intravenous cyclophosphamide therapy for lupus nephritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Cognitive effects of corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus Nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Remission of lupus nephritis with cyclophosphamide and late relapses following therapy withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

Growth and endocrine function in children receiving long-term steroid therapy for renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970109-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(00)70109-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657833%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference